StockData
Quantum Biopharma Ltd. logo

Quantum Biopharma Ltd. (QNTM) stock

QNTMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 26, 2026Score 1/30
$1.59+0.15 (+10.42%)

Close on Nov 17, 2026Market cap $6.18MP/E –Yield –

Quantum Biopharma cash

Cash and short-term investments held at the end of each period.

Quantum Biopharma's cash was $3.65M at Jun 30, 2026. For fiscal 2025 it was $1.91M, down 68.2% from the year before. The highest annual figure on record is $35.26M in fiscal 2021.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.91M-68.2%
FY2024Dec 31, 2024$6.00M+117.5%
FY2023Dec 31, 2023$2.76M-83.8%
FY2022Dec 31, 2022$16.98M-51.8%
FY2021Dec 31, 2021$35.26M+101.2%
FY2020Dec 31, 2020$17.52M+193.7%
FY2019Dec 31, 2019$5.97M-62.5%
FY2018Dec 31, 2018$15.90M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$3.65M+143.5%
Q1 FY2026Mar 31, 2026$4.34M+23.4%
Q4 FY2025Dec 31, 2025$1.91M-68.2%
Q3 FY2025Sep 30, 2025$445.94K-85.7%
Q2 FY2025Jun 30, 2025$1.50M-54.7%
Q1 FY2025Mar 31, 2025$3.52M+164.5%
Q4 FY2024Dec 31, 2024$6.00M+117.5%
Q3 FY2024Sep 30, 2024$3.12M-81.6%
Q2 FY2024Jun 30, 2024$3.31M-90.6%
Q1 FY2024Mar 31, 2024$1.33M-92.4%
Q4 FY2023Dec 31, 2023$2.76M-53.8%
Q4 FY2022Dec 31, 2022$16.98M+6.8%
Q4 FY2021Dec 31, 2021$35.26M–
Q4 FY2020Dec 31, 2020$17.52M–
Q4 FY2019Dec 31, 2019$5.97M–
Q4 FY2018Dec 31, 2018$15.90M–

More Quantum Biopharma figures

See a number that looks wrong?